Older HIV-positive patients in the era of highly active antiretroviral therapy
- 1 January 2003
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 17 (1), 128-131
- https://doi.org/10.1097/00002030-200301030-00020
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA)AIDS, 2002
- Decreased recovery of CD4 lymphocytes in older HIV-infected patients beginning highly active antiretroviral therapyAIDS, 2001
- Response to highly active antiretroviral therapy in HIV-infected patients aged 60 years or older after 24 months follow-upAIDS, 2001
- Influence of Age on CD4 Cell Recovery in Human Immunodeficiency Virus–Infected Patients Receiving Highly Active Antiretroviral Therapy: Evidence from the EuroSIDA StudyThe Journal of Infectious Diseases, 2001
- A case–control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced ageAIDS, 2000
- Predictors of Virological Success and Ensuing Failure in HIV-Positive Patients Starting Highly Active Antiretroviral Therapy in EuropeArchives of Internal Medicine, 2000
- Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimenAIDS, 1999
- AIDS and the ElderlyClinical Infectious Diseases, 1999
- Age as a prognostic factor in AIDSThe Lancet, 1996
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987